Retention of BA/BE samples [Regulatives / Guidelines]

posted by Neelu Singh – India, 2018-10-05 06:57 (1160 d 10:03 ago) – Posting: # 19409
Views: 1,506

Dear All,
My Question is:

Please provide clarification related to retention of BABE samples. Is it compulsory to retain pilot study samples or only retention of pivotal study samples are sufficient in order to follow the retention criteria?

1. As per CDSCO guideline "samples used in BA/BE study should be retained by organisation".
2. As per 21 CFR Sec. 320.38 Retention of bioavailability samples "retain an appropriately identified reserve sample of the drug product for which the applicant is seeking approval".

Complete thread:

 Admin contact
21,788 posts in 4,557 threads, 1,548 registered users;
online 3 (0 registered, 3 guests [including 2 identified bots]).
Forum time: Wednesday 16:00 CET (Europe/Vienna)

There is no adequate defense, except stupidity,
against the impact of a new idea.    Percy Williams Bridgman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz